Home › Immunoblastic Lymphadenopathy › Texas › Houston
Immunoblastic Lymphadenopathy clinical trials in Houston, TX
4 studies for Immunoblastic Lymphadenopathy are looking for participants at sites in and around Houston (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma
RecruitingPhase 3
- MD Anderson Cancer Center, Houston
A Study of ARV-393 in Relapsed/Refractory Non-Hodgkin Lymphoma.
RecruitingPhase 1
- Clinical Trial Site, Houston
A Registry for People With T-cell Lymphoma
RecruitingObservational study
- MD Anderson Cancer Center (Data Collection Only), Houston
Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma
RecruitingPhase 1
- The University of Texas MD Anderson Cancer Center, Houston
Immunoblastic Lymphadenopathy trials in other cities
- New York City, NY5 studies
- Chicago, IL4 studies
- Durham, NC4 studies
- Miami, FL4 studies
- Baldwin Park, CA3 studies
- Ann Arbor, MI3 studies
- St. Louis, MO3 studies
- Boston, MA3 studies
- New Haven, CT3 studies
- Columbus, OH3 studies
- Atlanta, GA3 studies
- Rochester, MN3 studies
Other studies in Houston
- Non-Small Cell Lung Cancer145 studies
- Breast Cancer126 studies
- Cancer (all types)121 studies
- Metastatic Cancer104 studies
- Colorectal Cancer102 studies
- Ovarian Cancer89 studies
- Acute Myeloid Leukemia85 studies
- Lung Cancer78 studies
- Prostate Cancer76 studies
- Endometrial Cancer68 studies
- Pancreatic Cancer61 studies
- Melanoma59 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.